Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
01/1997
01/29/1997EP0723453A4 Method of treating reproductive disorders
01/29/1997CN1141630A Substituted pyrazolyl benzenesulfonamides for treating inflammation
01/28/1997US5597894 Multi-tyrosinated somatostatin analogs
01/28/1997US5597797 Administering growth hormone and insulin-like growth factor
01/28/1997US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
01/28/1997CA2039194C Uses of l-deprenyl and compositions for same
01/23/1997WO1997002248A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
01/23/1997WO1996040072A3 Composition for sustained release of human growth hormone
01/22/1997EP0754456A2 Topical application of ST1435 as a contraceptive agent
01/22/1997EP0754048A1 Treatment of partial growth hormone insensitivity syndrome
01/22/1997EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds
01/22/1997CN1141058A In situ modification and manipulation of stem cells of the central nervous system
01/22/1997CN1140605A Channel tropism powder
01/21/1997US5595995 Anticarcinogenic agents
01/21/1997CA2022682C Cycloalkylene azoles, processes for their production and use, and pharmaceutical preparations obtained therefrom
01/16/1997WO1997001579A2 Somatostatin peptides
01/16/1997WO1997001342A1 Pharmaceutical combined preparation, kit and method for hormonal contraception
01/15/1997EP0752882A1 Treatment for juvenile diabetes
01/15/1997CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase
01/14/1997US5593884 Oncoprotein protein kinase
01/14/1997US5593658 Medical compositions
01/09/1997WO1997000894A1 Compounds with growth hormone releasing properties
01/09/1997WO1997000868A1 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
01/09/1997WO1997000693A1 Novel formulation for peptide release
01/09/1997WO1997000682A1 Compressed dry-granulation desogestrel tablets
01/09/1997CA2224434A1 Compounds with growth hormone releasing properties
01/09/1997CA2222266A1 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
01/08/1997EP0751769A1 Medical treatment using thyroid hormones
01/08/1997CN1033752C (1H-A201-1Ylmethyl) ubstituted quinoline, quinazoline or quinoxaline derivatives
01/03/1997WO1997000079A1 P-selectin ligands and related molecules and methods
01/03/1997CA2224625A1 P-selectin ligands and related molecules and methods
01/02/1997EP0750502A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
01/02/1997DE19525017A1 Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption Pharmaceutical Kombinatonspräparat, kit and method for hormonal contraception
12/1996
12/27/1996WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/27/1996WO1996041523A1 Fgf9 as a specific ligand for fgfr3
12/27/1996EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination
12/27/1996EP0749751A2 Pharmaceutical composition for use in tteatment of diabetes
12/27/1996CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/25/1996CN1138853A 1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists
12/25/1996CN1138472A Presciption and prepn. technique of "Ruzengning", for treatment of hyperplasia of mammary glands
12/24/1996US5587497 19-nor-vitamin D compounds
12/24/1996US5587496 15,15-dialkyl-substituted derivatives of estradiol
12/19/1996WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996WO1996040757A2 Lhrh antagonist peptides
12/19/1996WO1996040640A1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
12/19/1996WO1996040184A1 New cryptophycins from synthesis
12/19/1996WO1996040072A2 Composition for sustained release of human growth hormone
12/19/1996WO1996040048A2 Novel uses for thyroid hormones or thyroid hormone-like compounds
12/19/1996CA2223832A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996CA2223436A1 Composition for sustained release of human growth hormone
12/18/1996EP0748317A1 Novel thiazolidin-4-one derivatives
12/18/1996CN1138335A Compounds with growth hormone releasing properties
12/18/1996CN1138334A Compounds with growth hormone releasing properties
12/17/1996US5585404 3,5,3'-triiodothyronine receptor ligands
12/17/1996US5585376 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
12/12/1996WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996WO1996039372A2 Macrophage lipid chemoattractant
12/12/1996WO1996039162A1 Regulation of eating behavior
12/12/1996WO1996039161A1 Multi-tyrosinated somatostatin analogs
12/12/1996WO1996039158A1 Pineal gland specific gene-1
12/12/1996WO1996039140A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/12/1996WO1996019458A3 Steroid receptor modulator compounds and methods
12/12/1996CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996CA2223153A1 Regulation of eating behavior
12/12/1996CA2222962A1 Multi-tyrosinated somatostatin analogs
12/12/1996CA2222040A1 Macrophage lipid chemoattractant
12/12/1996CA2221842A1 Alpha 1a adrenergic receptor antagonists
12/11/1996EP0747346A2 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
12/11/1996CN1137525A Naphthyl compounds, intermediates, compositions, and methods
12/10/1996US5583138 Reductase inhibitor; skin disorders
12/10/1996US5583130 Benzo-fused lactams promote release of growth hormone
12/08/1996CA2176854A1 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
12/05/1996WO1996038471A1 Dipeptides which promote release of growth hormone
12/05/1996WO1996038167A1 Use of fibroblast growth factors to stimulate bone growth
12/04/1996EP0745081A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
12/04/1996EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/04/1996EP0744944A1 Sexual steroid-containing transdermal therapeutic systems
12/04/1996EP0744943A1 Desogestrel-containing transdermal application agent
12/04/1996EP0440738B1 Treatment of hypertension
12/03/1996US5580878 Treating sleep disorders
12/03/1996US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones
12/03/1996US5580572 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen
11/1996
11/28/1996WO1996037514A1 Chimeric fatty body-pro-grf analogs with increased biological potency
11/28/1996DE19517145C1 Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron Transdermal therapeutic system (TTS) for the administration of testosterone
11/27/1996CN1136779A Long-acting injection suspensions and process for their preparation
11/27/1996CN1136562A Estrogen excitant/antagonist
11/26/1996US5578724 Process for preparation of benzo[f]quinolinones
11/26/1996US5578588 Nasal administration of a precursor
11/20/1996CN1136318A 16-substituted -4-aza-androstane 5-alpha-reductase isoazyne 1 inhibitors
11/20/1996CN1136278A Combination of bisphosphonates and growth hormone secretagogues
11/14/1996WO1996035950A1 Inhibition of amylin release
11/14/1996WO1996035427A1 Transdermal therapeutic system for administering testosterone
11/14/1996WO1996015148A3 Low molecular weight peptidomimetic growth hormone secretagogues
11/14/1996CA2220358A1 Transdermal therapeutic system (tts) for the administration of testosterone
11/14/1996CA2220106A1 Inhibition of amylin release
11/13/1996EP0741578A1 Human growth hormone
11/13/1996CN1135488A Application of 19,11 beta-bridged sterodal compound in pharmaceutical working
11/12/1996US5574190 Naphthyl compounds, intermediates, compositions, and methods
11/12/1996US5574006 Nasally administrable peptide compositions on hydroxyapatite carriers
11/05/1996US5571925 Angiotensin II antagonists